glp 1 drugs for alcohol use disorder GLP-1 plus therapy can reduce heavy drinking Frontiers | The therapeutic potential

HARMONY or discord in cardiovascular outcome trials of GLP-1 receptor agonists

Living with hemophilia means balancing many aspects of daily health, from managing bleeding risks to being mindful of possible medication interactions

National Institute of Diabetes and Digestive and Kidney Diseases: Prescription Medications to Treat Overweight and Obesity Peterson-KFF Health System Tracker: Perspectives From Employers on the Costs and Issues Associated With Covering GLP-1 Agonists for Weight Loss Costly GLP-1 Drugs are Rarely Covered for Weight Loss by Marketplace Plans

Both classes lower blood glucose, promote weight loss, and reduce cardiovascular risk, but SGLT2 inhibitors have stronger evidence for kidney and heart failure protection and are generally preferred in those conditions